Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world
Authors:
Open Access
- 30 August 2018
- journal article
- research article
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 12 (11) , 2551-2558
Abstract
Background: The incidence and risk factors of chronic thromboembolic pulmonary hypertension (CTEPH) in patients with acute pulmonary embolism (PE) have been well reported. However, in real world, patients diagnosed with PE for the first time were usually composed of acute PE, sub‐acute PE, and chronic PE, and the cumulative incidence and risk factors of CTEPH in this cohort were still unknown.Methods: A prospective, long‐term, follow‐up study was conducted to assess the incidence of symptomatic CTEPH in consecutive patients with PE diagnosed for the first time. Patients with unexplained persistent dyspnea during follow‐up underwent transthoracic echocardiography and, if the findings indicated pulmonary hypertension, ventilation‐perfusion lung scanning and right heart catheterization. CTEPH was confirmed if perfusion defects were present, mean pulmonary artery pressure (mPAP) ≥25 mmHg and pulmonary artery wedge pressure (PAWP) ≤15 mmHg.Results: The cumulative incidence of CTEPH in patients with PE diagnosed for the first time was 11.2% at 3 months, 12.7% at 1 year, 13.4% at 2 years, and 14.5% at 3 years. The following factors increased the risk of CTEPH: time from symptoms to treatment of PE ≥1 month (odds ratio (OR), 14.77), intermediate (OR, 37.63) to high risk PE (OR, 39.81), segmental and sub‐segmental branch location of embolism (OR, 8.30) and PE‐related primary risk factors (OR, 5.01). 9.4% of CTEPH patients developed from acute PE, and 90.6% from sub‐acute and chronic PE.Conclusions: In real world, CTEPH is a relatively common and serious complication in PE patients diagnosed for the first time. Early diagnosis and treatment of PE will decrease the incidence of CTEPH in these unspecified patients.Keywords
Funding Information
- National Natural Science Foundation of China (81670045, 30871113, 81470249)
This publication has 10 references indexed in Scilit:
- Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk FactorsAnnals of the American Thoracic Society, 2016
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionPolish Heart Journal, 2015
- Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understandingEuropean Respiratory Journal, 2012
- Risk factors for chronic thromboembolic pulmonary hypertensionEuropean Respiratory Review, 2012
- Long-Term Outcomes in Acute Pulmonary ThromboembolismClinical and Applied Thrombosis/Hemostasis, 2012
- Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertensionBlood Coagulation & Fibrinolysis, 2010
- Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolismJournal of Thrombosis and Thrombolysis, 2010
- Risk factors for chronic thromboembolic pulmonary hypertensionEuropean Respiratory Journal, 2008
- Risk Factors for Chronic Thromboembolic Pulmonary HypertensionProceedings of the American Thoracic Society, 2006
- Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary EmbolismNew England Journal of Medicine, 2004